Rigorous administration of methotrexate and outcome of allogeneic blood stem cell transplantation.
Mehta
J
J
Singhal
S
S
D018952:Antigens, CD34 / Q000032:analysis; D006086:Graft vs Host Disease / Q000517:prevention & control*; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D053208:Kaplan-Meier Estimate; D008727:Methotrexate / Q000627:therapeutic use*; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
D018952:Antigens, CD34; D007166:Immunosuppressive Agents; D016179:Granulocyte Colony-Stimulating Factor; D008727:Methotrexate